Latest News about financial results
Recent news which mentions financial results
COMPASS Pathways Q2 2023: $148.2M Cash Position, Steady Quarter And 'Strong Progress Across The Business'
August 03, 2023
From Benzinga
Increased Production & Retail Sales For Magic Truffles: Red Light Holland Balances 2023 Financial Results
July 31, 2023
Tickers
TRUFF
From Benzinga
From Benzinga
Jack In The Box Partnership Helps Weedmaps Report Positive Q1 Earnings Despite Revenue Decrease
May 10, 2023
Tickers
MAPS
From Benzinga
Mydecine: 2022 Financials & Business Update By Next-Gen Psychedelics Producer, Smoke Cessation Trial And More
April 03, 2023
Tickers
MYCOF
From Benzinga
Filament Health: 2022 Financials And Operational Highlights From Creator Of The Ayahuasca Pill
April 03, 2023
From Benzinga
From Benzinga
MindMed Reports Full-Year 2022 Financial Results, Highlighting Anxiety & Autism Studies
March 10, 2023
Tickers
MNMD
From Benzinga
Braxia Scientific's Q3 2023 Finances, Update On Upcoming Acquisition With Irwin Naturals
March 02, 2023
From Benzinga
Field Trip H&W Closes Q3 2023 On Material Uncertainty, Need To Lower Costs & Adapt To New Regulations
March 01, 2023
Tickers
FTHWF
From Benzinga
Red Light Holland's Q3 2023 Financials: Expanded Farms Division, Home Grow Kits & Revenue Increase
February 27, 2023
Tickers
TRUFF
From Benzinga
Reunion Neuroscience Touts 'Transformative' Quarter, Reaffirms Postpartum Depression Treatment
February 14, 2023
Tickers
REUN
From Benzinga
Psychedelics Company Numinus Wellness Reports Q1 2023 Earnings, Initiatives For Wider Access
January 18, 2023
Tickers
NUMIF
From Benzinga
Mental Health Clinic Poised To Become Leader In A Projected $50B Industry, Analyst Says
December 09, 2022
Tickers
IWINF
From Benzinga
Why You Should Consider Investing In This Marijuana Stock: One Of Canada's Best Operators, Says Analyst
November 30, 2022
Tickers
OGI
From Benzinga
Biomind Labs: Q3 Financials & FDA Approval For New Chemical Entity Targeting Treatment-Resistant Depression
November 15, 2022
Tickers
BMNDF
From Benzinga
Cybin Shares Q2 Financial & Business Results, Focus On Licensing Deals For Preclinical Assets
November 15, 2022
Tickers
CYBN
From Benzinga
Filament Health Shares Q3 2022 Results, On Road To Becoming Industry's Natural Psilocybin Supplier
November 11, 2022
Tickers
FLHLF
From Benzinga
Atai Life Sciences' Q3 2022 Financials & Business Update, 'Strong Capability To Execute'
November 10, 2022
Tickers
ATAI
From Benzinga
Small Pharma's Q2 2023 Financial Results, 'Ultra Short-Acting Psychedelic Program' Underway
October 18, 2022
Tickers
DMTTF
From Benzinga
4 Psychedelics Companies Post Financial Results: Learn How Field Trip, Wesana, Braxia and Irwin Naturals Performed
August 30, 2022
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.